Summary

Persistence Market Research has recently published a detailed report on the global Pharmaceutical Excipients for Taste Masking Market. This report provides an in-depth evaluation of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering comprehensive insights into the market structure.

Key Insights:

• Pharmaceutical Excipients for Taste Masking Market Size (2024E): USD 985.6 million
• Projected Market Value (2033F): USD 1,539.2 million
• Global Market Growth Rate (CAGR 2024 to 2033): 5.1%

Pharmaceutical Excipients for Taste Masking Market - Report Scope:

Pharmaceutical excipients for taste masking are essential in medication formulation, enhancing patient compliance by concealing unpleasant tastes and odors. These excipients are utilized in various dosage forms, including tablets, syrups, and powders, to improve the palatability of pharmaceutical products. The market serves pharmaceutical manufacturers, contract research organizations (CROs), and contract manufacturing organizations (CMOs), providing a range of excipients such as flavoring agents, sweeteners, and coating materials.

Market Growth Drivers:

The global market for pharmaceutical excipients for taste masking is driven by several key factors, including the rising demand for pediatric and geriatric medicines, which require effective taste masking solutions to improve patient adherence. Increased consumer preference for orally administered medications and advancements in excipient technologies—such as the development of new flavor-masking agents and advanced coating materials—further contribute to market growth. Additionally, the expansion of the over-the-counter (OTC) pharmaceutical sector and the growing focus on personalized medicine drive the need for innovative taste masking solutions.

Market Restraints:

Despite optimistic growth prospects, the pharmaceutical excipients for taste masking market faces challenges such as the high cost of advanced excipient technologies and regulatory hurdles. Stringent regulations governing the safety and efficacy of excipients impose compliance burdens on manufacturers and increase operational costs. Moreover, the limited availability of taste masking solutions for certain drug formulations and the need for ongoing R&D investments to develop novel excipients present challenges for market penetration.

Market Opportunities:

The pharmaceutical excipients for taste masking market offers significant growth opportunities driven by technological innovations, demographic trends, and evolving pharmaceutical formulations. Advances in technologies, including nanotechnology and polymer-based excipients, enhance taste masking effectiveness and create new growth avenues. Furthermore, the expanding pharmaceutical industry in emerging markets and the increasing emphasis on patient-centric drug development provide opportunities for market players to introduce cost-effective and efficient taste masking solutions. Strategic partnerships, R&D investments, and the development of user-friendly excipients are essential for capitalizing on emerging opportunities and maintaining market leadership in the dynamic taste masking landscape.

Key Questions Answered in the Report:

• What are the primary factors driving global growth in the pharmaceutical excipients for taste masking market?
• Which excipient types and applications are driving taste masking adoption across various pharmaceutical formulations?
• How are technological advancements shaping the competitive landscape of the pharmaceutical excipients for taste masking market?
• Who are the major players in the pharmaceutical excipients for taste masking market, and what strategies are they employing to stay relevant?
• What are the emerging trends and future prospects in the global pharmaceutical excipients for taste masking market?

Competitive Intelligence and Business Strategy:

Leading companies in the global pharmaceutical excipients for taste masking market, including Ashland Global Holdings Inc., BASF SE, and DOW Chemical Company, focus on innovation, product differentiation, and strategic partnerships to gain a competitive advantage. These companies invest in R&D to develop advanced taste masking solutions, including novel flavor-masking agents and sophisticated coating materials, addressing diverse pharmaceutical needs and patient requirements. Collaborations with pharmaceutical manufacturers, research institutions, and regulatory agencies facilitate market access and encourage technology adoption. Additionally, a focus on clinical research, evidence-based practice, and patient education supports market growth and enhances patient outcomes in the evolving taste masking landscape.

Key Companies Profiled:

• Ashland Global Holdings Inc.
• BASF SE
• DOW Chemical Company
• Colorcon Inc.
• Ingredion Incorporated
• Roquette Frères
• JRS Pharma
• Lonza Group
• Evonik Industries AG
• Sensient Technologies Corporation

Key Segments Covered in Pharmaceutical Excipients for Taste Masking Industry Research

Excipient:
• Natural
• Artificial
• Nutritive
• Non- nutritive
• Polyols

Technique:
• Hot Melt Extrusion
• Microencapsulation
• Coating
• Organoleptic Methods

Usage:
• Solid Dosage Forms
• Liquid Dosage Forms

End-User:
• Pharmaceuticals
• Nutraceuticals
• Contract Manufacturing Organizations

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Excipient Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Recent Product Approval and Launches
4.4. Pipeline Assessment
4.5. PESTLE Analysis
4.6. Porter’s Analysis
4.7. Regulatory Scenario
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Excipient Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Geriatric Population
5.2.2. Technological Advancements
5.2.3. Adoption of Medicine for Paediatric Population
5.2.4. Increasing Chronic Diseases
5.2.5. Increasing Demand of Oral and Patients Compatible Medicines
5.2.6. Growth of The Top Companies
5.2.7. Mergers and Acquisitions
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis – Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Excipient
6.1.2. By Technique
6.1.3. By Usage
6.1.4. By End User
6.1.5. By Region
6.2. 2023 Market Scenario
7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Excipient
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Excipient, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Excipient, 2024-2033
8.3.1. Natural
8.3.2. Artificial
8.3.3. Nutritive
8.3.4. Non- nutritive
8.3.5. Polyols
8.3.6. Others
8.4. Market Attractiveness Analysis By Excipient
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Technique
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Technique, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2024-2033
9.3.1. Hot Melt Extrusion
9.3.2. Microencapsulation
9.3.3. Coating
9.3.4. Organoleptic Methods
9.3.5. Others
9.4. Market Attractiveness Analysis By Technique
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Usage
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Usage, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2024-2033
10.3.1. Solid Dosage Forms
10.3.1.1. Tablets
10.3.1.2. Granules
10.3.1.3. Capsules
10.3.2. Liquid Dosage Forms
10.4. Market Attractiveness Analysis By Usage
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
11.3.1. Pharmaceuticals
11.3.2. Nutraceuticals
11.3.3. Contract Manufacturing Organizations
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Excipient
13.3.3. By Technique
13.3.4. By Usage
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Excipient
13.4.3. By Technique
13.4.4. By Usage
13.4.5. By End User
13.5. Country Level Analysis & Forecast
13.5.1. U.S. Market Analysis
13.5.1.1. Introduction
13.5.1.2. Market Analysis and Forecast by Market Taxonomy
13.5.1.2.1. By Excipient
13.5.1.2.2. By Technique
13.5.1.2.3. By Usage
13.5.1.2.4. By End User
13.5.2. Canada Market Analysis
13.5.2.1. Introduction
13.5.2.2. Market Analysis and Forecast by Market Taxonomy
13.5.2.2.1. By Excipient
13.5.2.2.2. By Technique
13.5.2.2.3. By Usage
13.5.2.2.4. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Technique
14.3.3. By Usage
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Excipient
14.4.3. By Technique
14.4.4. By Usage
14.4.5. By End User
14.5. Country Level Analysis & Forecast
14.5.1. Brazil Market Analysis
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Excipient
14.5.1.2.2. By Technique
14.5.1.2.3. By Usage
14.5.1.2.4. By End User
14.5.2. Mexico Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Excipient
14.5.2.2.2. By Technique
14.5.2.2.3. By Usage
14.5.2.2.4. By End User
14.5.3. Argentina Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Excipient
14.5.3.2.2. By Technique
14.5.3.2.3. By Usage
14.5.3.2.4. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. France
15.3.1.3. Italy
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. BENELUX
15.3.1.8. Nordic Countries
15.3.1.9. Rest of Europe
15.3.2. By Excipient
15.3.3. By Technique
15.3.4. By Usage
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Excipient
15.4.3. By Technique
15.4.4. By Usage
15.4.5. By End User
15.5. Country Level Analysis & Forecast
15.5.1. Germany Market Analysis
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Excipient
15.5.1.2.2. By Technique
15.5.1.2.3. By Usage
15.5.1.2.4. By End User
15.5.2. France Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Excipient
15.5.2.2.2. By Technique
15.5.2.2.3. By Usage
15.5.2.2.4. By End User
15.5.3. Italy Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Excipient
15.5.3.2.2. By Technique
15.5.3.2.3. By Usage
15.5.3.2.4. By End User
15.5.4. U.K. Market Analysis
15.5.4.1. Introduction
15.5.4.2. Market Analysis and Forecast by Market Taxonomy
15.5.4.2.1. By Excipient
15.5.4.2.2. By Technique
15.5.4.2.3. By Usage
15.5.4.2.4. By End User
15.5.5. Spain Market Analysis
15.5.5.1. Introduction
15.5.5.2. Market Analysis and Forecast by Market Taxonomy
15.5.5.2.1. By Excipient
15.5.5.2.2. By Technique
15.5.5.2.3. By Usage
15.5.5.2.4. By End User
15.5.6. Russia Market Analysis
15.5.6.1. Introduction
15.5.6.2. Market Analysis and Forecast by Market Taxonomy
15.5.6.2.1. By Excipient
15.5.6.2.2. By Technique
15.5.6.2.3. By Usage
15.5.6.2.4. By End User
15.5.7. Nordic Countries Market Analysis
15.5.7.1. Introduction
15.5.7.2. Market Analysis and Forecast by Market Taxonomy
15.5.7.2.1. By Excipient
15.5.7.2.2. By Technique
15.5.7.2.3. By Usage
15.5.7.2.4. By End User
15.5.8. BENELUX Market Analysis
15.5.8.1. Introduction
15.5.8.2. Market Analysis and Forecast by Market Taxonomy
15.5.8.2.1. By Excipient
15.5.8.2.2. By Technique
15.5.8.2.3. By Usage
15.5.8.2.4. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Excipient
16.3.3. By Technique
16.3.4. By Usage
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Excipient
16.4.3. By Technique
16.4.4. By Usage
16.4.5. By End User
16.5. Country Level Analysis & Forecast
16.5.1. India Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Excipient
16.5.1.2.2. By Technique
16.5.1.2.3. By Usage
16.5.1.2.4. By End User
16.5.2. Thailand Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Excipient
16.5.2.2.2. By Technique
16.5.2.2.3. By Usage
16.5.2.2.4. By End User
16.5.3. Indonesia Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Excipient
16.5.3.2.2. By Technique
16.5.3.2.3. By Usage
16.5.3.2.4. By End User
16.5.4. Malaysia Market Analysis
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Excipient
16.5.4.2.2. By Technique
16.5.4.2.3. By Usage
16.5.4.2.4. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Excipient
17.3.3. By Technique
17.3.4. By Usage
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Excipient
17.4.3. By Technique
17.4.4. By Usage
17.4.5. By End User
17.5. Country Level Analysis & Forecast
17.5.1. China Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Excipient
17.5.1.2.2. By Technique
17.5.1.2.3. By Usage
17.5.1.2.4. By End User
17.5.2. Japan Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Excipient
17.5.2.2.2. By Technique
17.5.2.2.3. By Usage
17.5.2.2.4. By End User
17.5.3. South Korea Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Excipient
17.5.3.2.2. By Technique
17.5.3.2.3. By Usage
17.5.3.2.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Excipient
18.3.3. By Technique
18.3.4. By Usage
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Excipient
18.4.3. By Technique
18.4.4. By Usage
18.4.5. By End User
18.5. Country Level Analysis & Forecast
18.5.1. Australia Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Excipient
18.5.1.2.2. By Technique
18.5.1.2.3. By Usage
18.5.1.2.4. By End User
18.5.2. New Zealand Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Excipient
18.5.2.2.2. By Technique
18.5.2.2.3. By Usage
18.5.2.2.4. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Excipient
19.3.3. By Technique
19.3.4. By Usage
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Excipient
19.4.3. By Technique
19.4.4. By Usage
19.4.5. By End User
19.5. Country Level Analysis & Forecast
19.5.1. GCC Countries Market Analysis
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Excipient
19.5.1.2.2. By Technique
19.5.1.2.3. By Usage
19.5.1.2.4. By End User
19.5.2. Türkiye Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Excipient
19.5.2.2.2. By Technique
19.5.2.2.3. By Usage
19.5.2.2.4. By End User
19.5.3. Northern Africa Market Analysis
19.5.3.1. Introduction
19.5.3.2. Market Analysis and Forecast by Market Taxonomy
19.5.3.2.1. By Excipient
19.5.3.2.2. By Technique
19.5.3.2.3. By Usage
19.5.3.2.4. By End User
19.5.4. South Africa Market Analysis
19.5.4.1. Introduction
19.5.4.2. Market Analysis and Forecast by Market Taxonomy
19.5.4.2.1. By Excipient
19.5.4.2.2. By Technique
19.5.4.2.3. By Usage
19.5.4.2.4. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Branding and Promotional Strategies
21.3. Key Development Analysis
21.4. Competition Deep Dive
21.4.1. SPI Pharma, Inc.
21.4.1.1. Overview
21.4.1.2. Excipient Portfolio
21.4.1.3. Key financials
21.4.1.4. Sales Footprint
21.4.1.5. Strategy Overview
21.4.1.5.1. Marketing Strategy
21.4.1.5.2. Product Strategy
21.4.1.5.3. Channel Strategy
21.4.2. Adare Pharmaceutical Inc.
21.4.2.1. Overview
21.4.2.2. Excipient Portfolio
21.4.2.3. Key financials
21.4.2.4. Sales Footprint
21.4.2.5. Strategy Overview
21.4.2.5.1. Marketing Strategy
21.4.2.5.2. Product Strategy
21.4.2.5.3. Channel Strategy
21.4.3. GPT Pharmaceuticals Pvt. Ltd
21.4.3.1. Overview
21.4.3.2. Excipient Portfolio
21.4.3.3. Key financials
21.4.3.4. Sales Footprint
21.4.3.5. Strategy Overview
21.4.3.5.1. Marketing Strategy
21.4.3.5.2. Product Strategy
21.4.3.5.3. Channel Strategy
21.4.4. Roquette Frères
21.4.4.1. Overview
21.4.4.2. Excipient Portfolio
21.4.4.3. Key financials
21.4.4.4. Sales Footprint
21.4.4.5. Strategy Overview
21.4.4.5.1. Marketing Strategy
21.4.4.5.2. Product Strategy
21.4.4.5.3. Channel Strategy
21.4.5. Rochem International, Inc.
21.4.5.1. Overview
21.4.5.2. Excipient Portfolio
21.4.5.3. Key financials
21.4.5.4. Sales Footprint
21.4.5.5. Strategy Overview
21.4.5.5.1. Marketing Strategy
21.4.5.5.2. Product Strategy
21.4.5.5.3. Channel Strategy
21.4.6. Gattefose
21.4.6.1. Overview
21.4.6.2. Excipient Portfolio
21.4.6.3. Key financials
21.4.6.4. Sales Footprint
21.4.6.5. Strategy Overview
21.4.6.5.1. Marketing Strategy
21.4.6.5.2. Product Strategy
21.4.6.5.3. Channel Strategy
21.4.7. Asahi Kasei Corporation
21.4.7.1. Overview
21.4.7.2. Excipient Portfolio
21.4.7.3. Key financials
21.4.7.4. Sales Footprint
21.4.7.5. Strategy Overview
21.4.7.5.1. Marketing Strategy
21.4.7.5.2. Product Strategy
21.4.7.5.3. Channel Strategy
21.4.8. DuPont de Nemours, Inc
21.4.8.1. Overview
21.4.8.2. Excipient Portfolio
21.4.8.3. Key financials
21.4.8.4. Sales Footprint
21.4.8.5. Strategy Overview
21.4.8.5.1. Marketing Strategy
21.4.8.5.2. Product Strategy
21.4.8.5.3. Channel Strategy
21.4.9. Dow Pharma Solutions
21.4.9.1. Overview
21.4.9.2. Excipient Portfolio
21.4.9.3. Key financials
21.4.9.4. Sales Footprint
21.4.9.5. Strategy Overview
21.4.9.5.1. Marketing Strategy
21.4.9.5.2. Product Strategy
21.4.9.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology